TrendsWide
Contact US
  • Home
  • Trending
  • Health
  • Life Style
  • NBA
  • Reviews
No Result
View All Result
TrendsWide
  • Home
  • Trending
  • Health
  • Life Style
  • NBA
  • Reviews
No Result
View All Result
TrendsWide
No Result
View All Result
Home Economie

Morgan Stanley upgraded Five Below to ‘overweight’: here’s why

by souhaib
October 7, 2021
in Economie
0
Morgan Stanley upgraded Five Below to ‘overweight’: here’s why
74
SHARES
1.2k
VIEWS
Share on FacebookShare on TwitterShare on Reddit
ADVERTISEMENT


Five Below Inc (NASDAQ: FIVE) has tanked about 20% since late August after it reported lower-than-expected quarterly revenue on rising inflation and supply chain constraints.

Analyst Simeon Gutman sees upside to $230

While the risks still persist, Morgan Stanley is convinced the dip makes up for a buying opportunity with an upside to $230.


Are you looking for fast-news, hot-tips and market analysis?

Sign-up for the Invezz newsletter, today.

In a note this morning, Morgan Stanley’s Simeon Gutman upgraded the stock to “overweight”, saying it’s a “good compounded growth story” that is trading at a discount and is well-positioned to weather inflationary costs.

Five jumped more than 6.0% today on the bullish call – its best day since June. The $10.44 billion company has a price to earnings ratio of 40.49.

Gutman defends his bullish call on CNBC’s “The Exchange”

On CNBC’s “The Exchange”, Gutman appreciated that Five Below was no longer limiting its inventory to a $5 cap citing the “environment called for it”. He said:

They’ve broken their $5 threshold for higher quality or more aspirational items. As long as they’re delivering value to customers within that $5 to $10 range, they’ll keep coming back.

According to Gutman, investors are concerned if smaller retailers would be able to “manage costs” and “get inventory” amidst inflation. But Five Below, he added, has “shorted out those fears”.

In our meeting with the company yesterday, Five Below delivered a surprisingly good, benign inventory picture. They’ve been planning for this environment for a while. They’ve been buying forward, they’re very connected to their merchants and have great visibility.

Invest in crypto, stocks, ETFs & more in minutes with our preferred broker,

eToro






10/10

67% of retail CFD accounts lose money



Source link

You might also like

‘momentum is continuing into 2022’

Astra Space stock closed down 20% on Monday: here’s why

Ripple, Dogecoin, Litecoin price forecast for February 2022

Share30Tweet19Share
Previous Post

Is Freeport-McMoRan stock a buy amid surging copper price?

Next Post

Should you buy or sell ALLO stock after shares plunge 37% as FDA halts clinical trial?

souhaib

Recommended For You

‘momentum is continuing into 2022’

by souhaib
February 7, 2022
0
‘momentum is continuing into 2022’

Shares of Chegg Inc (NYSE: CHGG) are up 10% in extended trading on Monday after the student services company said it performed better-than-expected in Q4, despite COVID-19 uncertainty....

Read more

Astra Space stock closed down 20% on Monday: here’s why

by souhaib
February 7, 2022
0
Astra Space stock closed down 20% on Monday: here’s why

Read more

Ripple, Dogecoin, Litecoin price forecast for February 2022

by souhaib
February 7, 2022
0
Ripple, Dogecoin, Litecoin price forecast for February 2022

The cryptocurrency market is advancing this Monday, and this situation also supports the price of Ripple XRP/USD, Dogecoin DOGE/USD, and Litecoin LTC/USD. Bitcoin is trading above the $44,000...

Read more

Analyst: ‘Apple would be forced into it if Amazon goes after Peloton’

by souhaib
February 7, 2022
0
Analyst: ‘Apple would be forced into it if Amazon goes after Peloton’

Read more

Should I buy Uber shares in February 2022?

by souhaib
February 7, 2022
0
Should I buy Uber shares in February 2022?

Uber Technologies, Inc. (NYSE: UBER) will announce fourth-quarter earnings results this Wednesday, February 09, after the market closes. Uber shares have weakened more than 10% since the beginning...

Read more
Next Post
Should you buy or sell ALLO stock after shares plunge 37% as FDA halts clinical trial?

Should you buy or sell ALLO stock after shares plunge 37% as FDA halts clinical trial?

No Result
View All Result

Recent Posts

  • GameStop shares plummet after fifth CEO exit in 5 years
  • Biden Vetoes GOP-Led Bill Blocking Student Debt Relief
  • Pope spends first night in hospital
  • Brit dragged into Italian murder case as it’s revealed she was in relationship with accused murderer
  • The alert level for the eruption of the Kilauea volcano in Hawaii increases; the park service shares the best places to see the exhibit

Browse by Category

  • Australia
  • Automotive
  • Business
  • Celebrity
  • Cryptocurrency
  • Deals
  • Economie
  • Education
  • Entertainment
  • Euro
  • Forex
  • Gaming
  • Health
  • Life Style
  • NBA
  • News
  • Politics
  • Reviews
  • Sports
  • Switzerland
  • Trending
  • U.S.
  • Uncategorized

Categories

  • Australia
  • Automotive
  • Business
  • Celebrity
  • Cryptocurrency
  • Deals
  • Economie
  • Education
  • Entertainment
  • Euro
  • Forex
  • Gaming
  • Health
  • Life Style
  • NBA
  • News
  • Politics
  • Reviews
  • Sports
  • Switzerland
  • Trending
  • U.S.
  • Uncategorized

Pages

  • Contact US
  • Newsletter
  • Privacy Policy
  • Terms & Conditions

© 2021 - TrendsWide

No Result
View All Result
  • Home
  • Contact US
  • Privacy Policy
  • Trending
  • U.S.
  • Economie
  • Deals
  • Reviews
  • Cryptocurrency
  • Health
  • Life Style
  • NBA

© 2021 - TrendsWide